Stuart I. Ward
Charles River Laboratories (United Kingdom)(GB)
Publications by Year
Research Areas
Cytokine Signaling Pathways and Interactions, Myeloproliferative Neoplasms: Diagnosis and Treatment, Neurobiology and Insect Physiology Research, Ion Channels and Receptors, Phytochemicals and Antioxidant Activities
Most-Cited Works
- → Identification of Imidazo-Pyrrolopyridines as Novel and Potent JAK1 Inhibitors(2012)92 cited
- → Identification of C-2 Hydroxyethyl Imidazopyrrolopyridines as Potent JAK1 Inhibitors with Favorable Physicochemical Properties and High Selectivity over JAK2(2013)62 cited
- → Discovery and Optimization of C-2 Methyl Imidazopyrrolopyridines as Potent and Orally Bioavailable JAK1 Inhibitors with Selectivity over JAK2(2012)61 cited
- → Tetrahydrofuran-Based Transient Receptor Potential Ankyrin 1 (TRPA1) Antagonists: Ligand-Based Discovery, Activity in a Rodent Asthma Model, and Mechanism-of-Action via Cryogenic Electron Microscopy(2021)49 cited
- → A reversed sulfonamide series of selective RORc inverse agonists(2014)35 cited
- → TRPA1 modulation by piperidine carboxamides suggests an evolutionarily conserved binding site and gating mechanism(2019)29 cited
- → Azepines and Piperidines with Dual Norepinephrine Dopamine Uptake Inhibition and Antidepressant Activity(2012)27 cited
- → Structure-based discovery of C-2 substituted imidazo-pyrrolopyridine JAK1 inhibitors with improved selectivity over JAK2(2012)24 cited
- → Novel triazolo-pyrrolopyridines as inhibitors of Janus kinase 1(2013)19 cited
- → 5-Aminopyrimidin-2-ylnitriles as Cathepsin K inhibitors(2009)13 cited